A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial

Bernard Chevalier; Carlo Dimario; Franz-Josef Neumann; Donald E Cutlip; David O Williams; John Ormiston; Eberhard Grube; Robert Whitbourn; Jessie Coe; Lewis B Schwartz; ZOMAXX I Investigators; Kari Saunamäki

doi:10.1002/ccd.24958

A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial

Bernard Chevalier, Carlo Dimario, Franz-Josef Neumann, Donald E Cutlip, David O Williams, John Ormiston, Eberhard Grube, Robert Whitbourn, Jessie Coe, Lewis B Schwartz, ZOMAXX I Investigators, Kari Saunamäki

6 Citationer (Scopus)

Abstract

The ZOMAXX I trial tested the noninferiority of a zotarolimus-eluting coronary stent (ZoMaxx(™) ) when compared with a paclitaxel-eluting coronary stent (Taxus(™) Express(2™) ) in a randomized trial of percutaneous intervention for de novo coronary artery stenosis. Angiographic analysis at the primary endpoint of 9 months has been reported previously. The purpose of this follow-on analysis was to describe the clinical results of the ZoMaxx and Taxus cohorts of the ZOMAXX I trial after 5 years.

Originalsprog	Engelsk
Tidsskrift	Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Vol/bind	82
Udgave nummer	7
Sider (fra-til)	1039-47
Antal sider	9
ISSN	1522-1946
DOI	https://doi.org/10.1002/ccd.24958
Status	Udgivet - 1 dec. 2013

Adgang til dokumentet

10.1002/ccd.24958

Fingeraftryk

Dyk ned i forskningsemnerne om 'A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Chevalier, B., Dimario, C., Neumann, F.-J., Cutlip, D. E., Williams, D. O., Ormiston, J., Grube, E., Whitbourn, R., Coe, J., Schwartz, L. B., ZOMAXX I Investigators, & Saunamäki, K. (2013). A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 82(7), 1039-47. https://doi.org/10.1002/ccd.24958

A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial. / Chevalier, Bernard; Dimario, Carlo; Neumann, Franz-Josef et al.
I: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, Bind 82, Nr. 7, 01.12.2013, s. 1039-47.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Chevalier, B, Dimario, C, Neumann, F-J, Cutlip, DE, Williams, DO, Ormiston, J, Grube, E, Whitbourn, R, Coe, J, Schwartz, LB, ZOMAXX I Investigators & Saunamäki, K 2013, 'A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial', Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, bind 82, nr. 7, s. 1039-47. https://doi.org/10.1002/ccd.24958

Chevalier B, Dimario C, Neumann FJ, Cutlip DE, Williams DO, Ormiston J et al. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2013 dec. 1;82(7):1039-47. doi: 10.1002/ccd.24958

Chevalier, Bernard ; Dimario, Carlo ; Neumann, Franz-Josef et al. / A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries : five-year results from the ZOMAXX I trial. I: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2013 ; Bind 82, Nr. 7. s. 1039-47.

@article{0170d48333b14ae8b6be25187e44b9f3,

title = "A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial",

abstract = "The ZOMAXX I trial tested the noninferiority of a zotarolimus-eluting coronary stent (ZoMaxx({\texttrademark}) ) when compared with a paclitaxel-eluting coronary stent (Taxus({\texttrademark}) Express(2{\texttrademark}) ) in a randomized trial of percutaneous intervention for de novo coronary artery stenosis. Angiographic analysis at the primary endpoint of 9 months has been reported previously. The purpose of this follow-on analysis was to describe the clinical results of the ZoMaxx and Taxus cohorts of the ZOMAXX I trial after 5 years.",

author = "Bernard Chevalier and Carlo Dimario and Franz-Josef Neumann and Cutlip, {Donald E} and Williams, {David O} and John Ormiston and Eberhard Grube and Robert Whitbourn and Jessie Coe and Schwartz, {Lewis B} and {ZOMAXX I Investigators} and Kari Saunam{\"a}ki",

note = "Copyright {\textcopyright} 2013 Wiley Periodicals, Inc.",

year = "2013",

month = dec,

day = "1",

doi = "10.1002/ccd.24958",

language = "English",

volume = "82",

pages = "1039--47",

journal = "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions",

issn = "1522-1946",

publisher = "John/Wiley & Sons, Inc. John/Wiley & Sons Ltd",

number = "7",

}

TY - JOUR

T1 - A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries

T2 - five-year results from the ZOMAXX I trial

AU - Chevalier, Bernard

AU - Dimario, Carlo

AU - Neumann, Franz-Josef

AU - Cutlip, Donald E

AU - Williams, David O

AU - Ormiston, John

AU - Grube, Eberhard

AU - Whitbourn, Robert

AU - Coe, Jessie

AU - Schwartz, Lewis B

AU - ZOMAXX I Investigators

AU - Saunamäki, Kari

PY - 2013/12/1

Y1 - 2013/12/1

N2 - The ZOMAXX I trial tested the noninferiority of a zotarolimus-eluting coronary stent (ZoMaxx(™) ) when compared with a paclitaxel-eluting coronary stent (Taxus(™) Express(2™) ) in a randomized trial of percutaneous intervention for de novo coronary artery stenosis. Angiographic analysis at the primary endpoint of 9 months has been reported previously. The purpose of this follow-on analysis was to describe the clinical results of the ZoMaxx and Taxus cohorts of the ZOMAXX I trial after 5 years.

AB - The ZOMAXX I trial tested the noninferiority of a zotarolimus-eluting coronary stent (ZoMaxx(™) ) when compared with a paclitaxel-eluting coronary stent (Taxus(™) Express(2™) ) in a randomized trial of percutaneous intervention for de novo coronary artery stenosis. Angiographic analysis at the primary endpoint of 9 months has been reported previously. The purpose of this follow-on analysis was to describe the clinical results of the ZoMaxx and Taxus cohorts of the ZOMAXX I trial after 5 years.

U2 - 10.1002/ccd.24958

DO - 10.1002/ccd.24958

M3 - Journal article

C2 - 23592567

SN - 1522-1946

VL - 82

SP - 1039

EP - 1047

JO - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

JF - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

IS - 7

ER -